Robert S Schwartz

Summary

Affiliation: Minnesota Cardiovascular Research Institute
Country: USA

Publications

  1. ncbi Detecting vulnerable plaque using peripheral blood: inflammatory and cellular markers
    Robert S Schwartz
    Minnesota Cardiovascular Research Institute, Minneapolis Heart Institute Foundation, Minneapolis, MN 55407, USA
    J Interv Cardiol 16:231-42. 2003
  2. doi Microemboli and microvascular obstruction in acute coronary thrombosis and sudden coronary death: relation to epicardial plaque histopathology
    Robert S Schwartz
    Minneapolis Heart Institute and Foundation, 920 East 28th Street, Suite 620, Minneapolis, Minnesota 55407 E mail
    J Am Coll Cardiol 54:2167-73. 2009
  3. doi Left atrial appendage obliteration: mechanisms of healing and intracardiac integration
    Robert S Schwartz
    Minneapolis Heart Institute and Foundation, Minneapolis, Minnesota 55407, USA
    JACC Cardiovasc Interv 3:870-7. 2010
  4. pmc Drug-eluting stents in preclinical studies: updated consensus recommendations for preclinical evaluation
    Robert S Schwartz
    Minneapolis Heart Institute and Foundation, 920 E 28th Street, Suite 600, Minneapolis, MN 55407
    Circ Cardiovasc Interv 1:143-53. 2008
  5. ncbi Ionizing radiation and the coronary arteries: the plot is thickening!
    Robert S Schwartz
    Minneapolis Heart Institute and Foundation, Minneapolis, Minnesota 55407, USA
    Catheter Cardiovasc Interv 70:366-7. 2007
  6. ncbi Images in cardiovascular medicine. Ruptured plaque visualization by noninvasive coronary computed tomography angiography
    John R Lesser
    Minnesota Cardiovascular Research Institute, Minneapolis Heart Institute Foundation, 920 E 28th St Suite 300, Minneapolis, MN 55407, USA
    Circulation 110:e311-2. 2004
  7. ncbi Drug-eluting stents in preclinical studies: recommended evaluation from a consensus group
    Robert S Schwartz
    Minnesota Cardiovascular Research Institute and Minneapolis Heart Institute Foundation Minneapolis, 55407, USA
    Circulation 106:1867-73. 2002
  8. ncbi Preclinical restenosis models and drug-eluting stents: still important, still much to learn
    Robert S Schwartz
    Minneapolis Heart Institute, Minneapolis, Minnesota 55407, USA
    J Am Coll Cardiol 44:1373-85. 2004
  9. ncbi Preclinical evaluation of drug-eluting stents for peripheral applications: recommendations from an expert consensus group
    Robert S Schwartz
    Minneapolis Heart Institute Foundation, Minnesota Cardiovascular Research Institute, 920 E 28th St, Minneapolis, MN 55407, USA
    Circulation 110:2498-505. 2004
  10. ncbi Percutaneous balloon aortic valvuloplasty revisited: time for a renaissance?
    Hidehiko Hara
    Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minn 55407, USA
    Circulation 115:e334-8. 2007

Detail Information

Publications71

  1. ncbi Detecting vulnerable plaque using peripheral blood: inflammatory and cellular markers
    Robert S Schwartz
    Minnesota Cardiovascular Research Institute, Minneapolis Heart Institute Foundation, Minneapolis, MN 55407, USA
    J Interv Cardiol 16:231-42. 2003
    ..Sensitivity or specificity must be increased by developing a risk marker panel, or by simultaneously finding other markers that themselves are highly sensitive and specific for vulnerable plaque...
  2. doi Microemboli and microvascular obstruction in acute coronary thrombosis and sudden coronary death: relation to epicardial plaque histopathology
    Robert S Schwartz
    Minneapolis Heart Institute and Foundation, 920 East 28th Street, Suite 620, Minneapolis, Minnesota 55407 E mail
    J Am Coll Cardiol 54:2167-73. 2009
    ..This study examined myocardial microvascular emboli and obstruction, and related these to plaque in the epicardial coronary arteries supplying the affected microvessels...
  3. doi Left atrial appendage obliteration: mechanisms of healing and intracardiac integration
    Robert S Schwartz
    Minneapolis Heart Institute and Foundation, Minneapolis, Minnesota 55407, USA
    JACC Cardiovasc Interv 3:870-7. 2010
    ....
  4. pmc Drug-eluting stents in preclinical studies: updated consensus recommendations for preclinical evaluation
    Robert S Schwartz
    Minneapolis Heart Institute and Foundation, 920 E 28th Street, Suite 600, Minneapolis, MN 55407
    Circ Cardiovasc Interv 1:143-53. 2008
    ..This expert consensus document is consistent with the Food and Drug Administration guidance. The dynamic nature of this field mandates future modifications and additions that will be added over time...
  5. ncbi Ionizing radiation and the coronary arteries: the plot is thickening!
    Robert S Schwartz
    Minneapolis Heart Institute and Foundation, Minneapolis, Minnesota 55407, USA
    Catheter Cardiovasc Interv 70:366-7. 2007
  6. ncbi Images in cardiovascular medicine. Ruptured plaque visualization by noninvasive coronary computed tomography angiography
    John R Lesser
    Minnesota Cardiovascular Research Institute, Minneapolis Heart Institute Foundation, 920 E 28th St Suite 300, Minneapolis, MN 55407, USA
    Circulation 110:e311-2. 2004
  7. ncbi Drug-eluting stents in preclinical studies: recommended evaluation from a consensus group
    Robert S Schwartz
    Minnesota Cardiovascular Research Institute and Minneapolis Heart Institute Foundation Minneapolis, 55407, USA
    Circulation 106:1867-73. 2002
  8. ncbi Preclinical restenosis models and drug-eluting stents: still important, still much to learn
    Robert S Schwartz
    Minneapolis Heart Institute, Minneapolis, Minnesota 55407, USA
    J Am Coll Cardiol 44:1373-85. 2004
    ..Ongoing research into animal models will reconcile apparent differences with clinical trials and advance our understanding of how to apply animal models to clinical stenting in the era of DESs...
  9. ncbi Preclinical evaluation of drug-eluting stents for peripheral applications: recommendations from an expert consensus group
    Robert S Schwartz
    Minneapolis Heart Institute Foundation, Minnesota Cardiovascular Research Institute, 920 E 28th St, Minneapolis, MN 55407, USA
    Circulation 110:2498-505. 2004
  10. ncbi Percutaneous balloon aortic valvuloplasty revisited: time for a renaissance?
    Hidehiko Hara
    Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minn 55407, USA
    Circulation 115:e334-8. 2007
  11. ncbi Preclinical restenosis models: challenges and successes
    Arturo G Touchard
    Minneapolis Heart Institute, Minneapolis, Minnesota 55407, USA
    Toxicol Pathol 34:11-8. 2006
    ..A key question in the era of intravascular technologies is how well this and other models can predict clinical events. This paper discusses the models and their application...
  12. doi Is the left atrial appendage more than a simple appendage?
    Hidehiko Hara
    Minneapolis Heart Institute and Foundation, Minneapolis, Minnesota, USA
    Catheter Cardiovasc Interv 74:234-42. 2009
    ..The feasibility of this treatment is now established, suggesting that percutaneous therapy is safe, practical and possibly effective to eliminate the need for anticoagulation and significantly reduce cardioembolic events...
  13. doi Comparison of outcomes in high-risk patients>70 years of age with aortic valvuloplasty and percutaneous coronary intervention versus aortic valvuloplasty alone
    Wes R Pedersen
    Minneapolis Heart Institute Foundation at Abbott Northwestern Hospital, Minneapolis, Minnesota, USA
    Am J Cardiol 101:1309-14. 2008
    ..2+/-27.3 minutes and 3.3+/-2.1 days, respectively. In conclusion, with appropriate selection, BAV plus PCI was safely performed in this retrospective series of elderly, high-risk patients with severe AS and CAD...
  14. ncbi Feasibility of transcatheter intervention for severe aortic stenosis in patients >or=90 years of age: aortic valvuloplasty revisited
    Wes R Pedersen
    Minneapolis Heart Institute Foundation at Abbott Northwestern Hospital, Minneapolis, Minnesota 55407, USA
    Catheter Cardiovasc Interv 70:149-54. 2007
    ..The goals of this study were to determine the feasibility, safety, and early outcomes of balloon aortic valvuloplasty (BAV) for severe aortic stenosis in a nonagenarian population...
  15. ncbi Zotarolimus-eluting stents reduce experimental coronary artery neointimal hyperplasia after 4 weeks
    Arturo Garcia-Touchard
    Minneapolis Heart Institute and Foundation, Minneapolis Heart Institute, 920 E 28th St, Suite 620, Minneapolis, MN 55407, USA
    Eur Heart J 27:988-93. 2006
    ....
  16. ncbi Clinical utility of coronary CT angiography: coronary stenosis detection and prognosis in ambulatory patients
    John R Lesser
    Minneapolis Heart Institute and Foundation, Minneapolis, Minnesota 55407, USA
    Catheter Cardiovasc Interv 69:64-72. 2007
    ..This study retrospectively analyzed MSCTA performance in a large outpatient cohort and examined 6-month clinical follow-up in those without invasive CA...
  17. ncbi Patent foramen ovale closure by radiofrequency thermal coaptation: first experience in the porcine model and healing mechanisms over time
    Hidehiko Hara
    Minneapolis Heart Institute and Foundation, 920 E 28th St, Minneapolis, MN 55407, USA
    Circulation 116:648-53. 2007
    ..A novel strategy uses radiofrequency-based thermal energy to seal PFO membranes, with no implanted device. We successfully used this method and examined histopathologic events in swine to characterize safety and efficacy...
  18. doi Balloon aortic valvuloplasty in high risk aortic stenosis patients with left ventricular ejection fractions <20%
    Wes R Pedersen
    Structural Heart Disease Program, Cardiovascular Services, Minneapolis Heart Institute at Abbott Northwestern Hospital, Minneapolis, Minnesota Research Department, Minneapolis Heart Institute Foundation, Minneapolis, Minnesota
    Catheter Cardiovasc Interv 84:824-31. 2014
    ..To determine outcomes following balloon aortic valvuloplasty (BAV) in aortic stenosis (AS) patients with a left ventricular ejection fraction (LVEF) <20%...
  19. ncbi Pathophysiology of coronary artery restenosis
    Robert S Schwartz
    Minnesota Cardiovascular Research Institute, Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA
    Rev Cardiovasc Med 3:S4-9. 2002
    ..This article reviews arterial injury during revascularization in both patients and animal models and discusses the nature and formation of neointimal hyperplasia...
  20. ncbi Role of stent design and coatings on restenosis and thrombosis
    Hidehiko Hara
    Minnesota Cardiovascular Research Institute, Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, 920 East 28th Street Suite 620, Minneapolis, MN, 55407, USA
    Adv Drug Deliv Rev 58:377-86. 2006
    ..This chapter describes stents which have subtle influences of modular design, metal coverage, strut thickness, strut shape, surface smoothness, and coating materials like an alloy composition...
  21. ncbi Patent foramen ovale: standards for a preclinical model of prevalence, structure, and histopathologic comparability to human hearts
    Hidehiko Hara
    Minneapolis Heart Institute and Foundation, Minneapolis, Minnesota 55407, USA
    Catheter Cardiovasc Interv 69:266-73. 2007
    ..This study evaluated and standardized a Patent Foramen Ovale (PFO) preclinical model in gross anatomic and histopathologic features...
  22. ncbi Microvascular obstruction in acute coronary syndromes: onward to a new therapeutic target
    Robert S Schwartz
    Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA
    Catheter Cardiovasc Interv 66:170-2. 2005
  23. doi Identification of unexpected nonatherosclerotic cardiovascular disease with coronary CT angiography
    Thomas Knickelbine
    Cardiovascular Services, Minneapolis Heart Institute, Minneapolis, Minnesota 55407, USA
    JACC Cardiovasc Imaging 2:1085-92. 2009
    ....
  24. doi Left atrial remodeling in hypertrophic cardiomyopathy and susceptibility markers for atrial fibrillation identified by cardiovascular magnetic resonance
    Barry J Maron
    Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, Minneapolis, Minnesota Electronic address
    Am J Cardiol 113:1394-400. 2014
    ..In conclusion, CMR measures of LA remodeling and dysfunction reliably identified patients with HC at risk for future development of AF. Decrease in LAEF represents a strong novel marker of susceptibility to AF in this disease...
  25. ncbi Radiation following percutaneous balloon aortic valvuloplasty to prevent restenosis (RADAR pilot trial)
    Wes R Pedersen
    Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota 55407, USA
    Catheter Cardiovasc Interv 68:183-92. 2006
    ..We wished to determine the feasibility and early safety of external beam radiation therapy (EBRT) used following balloon aortic valvuloplasty (BAV) to prevent restenosis...
  26. ncbi Images in cardiovascular medicine. Myocardial rupture, microvascular obstruction, and infarct expansion: elucidation by cardiac magnetic resonance
    John R Lesser
    Minneapolis Heart Institute Foundation, Minneapolis, MN 55407, USA
    Circulation 108:116-7. 2003
  27. ncbi Long-Term Marathon Running Is Associated with Low Coronary Plaque Formation in Women
    William O Roberts
    1Department of Family Medicine and Community Health, University of Minnesota, Minneapolis, MN 2Minneapolis Heart Institute and Foundation at Abbott Northwestern Hospital, Minneapolis, MN 3The Integra Group, Brooklyn Park, MN 4Stanford University School of Medicine, Stanford CA 5Division of Cardiology, Department of Medicine, University of Minnesota, Minneapolis, MN 6Retired Medtronic Inc, Minneapolis, MN 7Department of Internal Medicine, University of Arizona, Tucson, AZ
    Med Sci Sports Exerc . 2016
    ..High resolution coronary computed tomography angiography (CCTA) and a cardiac risk factor assessment were completed in women with long term marathon running histories to compare to sedentary women with similar risk factors...
  28. doi The right atrium and tricuspid annulus are cardinal structures in tricuspid regurgitation with or without pulmonary hypertension
    Naohiko Nemoto
    Minneapolis Heart Institute and Foundation, Minneapolis, MN, United States
    Int J Cardiol . 2016
    ..They may occur independently or together, but their joint effects on cardiac structure are incompletely described. This study examined the interactions of TR severity and PH on right heart structural changes...
  29. doi Safety and accuracy of dual-source coronary computed tomography angiography in the pediatric population
    B Kelly Han
    Children s Heart Clinic Minneapolis, MN, USA
    J Cardiovasc Comput Tomogr 6:252-9. 2012
    ..High heart rates and radiation sensitivity have limited the use of coronary computed tomography angiography (CTA) in pediatric patients...
  30. ncbi Direct stenting: good for the patient, good for all?
    Arturo G Touchard
    Minneapolis Heart Institute, Minnesota Cardiovascular Research Institute, Minnesota, USA
    J Invasive Cardiol 15:120. 2003
  31. ncbi "False-positive" cardiac catheterization laboratory activation among patients with suspected ST-segment elevation myocardial infarction
    David M Larson
    Minneapolis Heart Institute Foundation at Abbott Northwestern Hospital, Minneapolis, Minnesota 55407, USA
    JAMA 298:2754-60. 2007
    ..There are limited data on the frequency of "false-positive" catheterization laboratory activation in patients undergoing percutaneous coronary intervention for suspected STEMI...
  32. ncbi Pottery heart: a case of porcelain heart
    Hidehiko Hara
    Minneapolis Heart Institute and Foundation, Minneapolis, MN 55407, USA
    Cardiovasc Revasc Med 8:80-1. 2007
    ..Minnetonka, MN). Three-dimensional volume-rendering technique imaging reveals massive calcification of the entire heart, creating a pottery appearance...
  33. ncbi Pregnancy-associated plasma protein-A elevation in patients with acute coronary syndrome and subsequent atorvastatin therapy
    Michael D Miedema
    Minneapolis Heart Institute and Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA
    Am J Cardiol 101:35-9. 2008
    ..High-dose atorvastatin significantly decreased PAPP-A at 1 month and hs-CRP at 6 months in patients with verified CAD. Low-dose atorvastatin did not produce this effect...
  34. doi Practical approaches to overcoming artifacts in coronary CT angiography
    John R Lesser
    Minneapolis Heart Institute Foundation, 920 E 28th Street, Suite 300, Minneapolis, MN 55407, USA
    J Cardiovasc Comput Tomogr 3:4-15. 2009
    ..In addition, tables link the likelihood that a specific cause of an artifact will allow a scan to be salvaged. An approach for interpreting scans with excess noise is also discussed...
  35. ncbi Extracellular proteases in atherosclerosis and restenosis
    Arturo Garcia-Touchard
    Minnesota Cardiovascular Research Institute, Minneapolis Heart Institute, Minneapolis, Minn 55407, USA
    Arterioscler Thromb Vasc Biol 25:1119-27. 2005
    ..These broad extracellular protease functions make them potentially interesting therapeutic targets...
  36. doi Use of cardiac CT angiography to assist in the diagnosis and treatment of aortic prosthetic paravalvular leak: a practical guide
    John R Lesser
    The Minneapolis Heart Institute and Foundation, Suite 300, 920 East 28th Street, Minneapolis, MN 55407, USA Electronic address
    J Cardiovasc Comput Tomogr 9:159-64. 2015
    ..This approach can be used to minimize inaccuracies in the diagnosis and enhance the procedural success for percutaneous repair of aortic paravalvular regurgitation...
  37. doi Accuracy and safety of high pitch computed tomography imaging in young children with complex congenital heart disease
    B Kelly Han
    Children s Heart Clinic and Children s Hospital of Minnesota, Minneapolis, Minnesota Minneapolis Heart Institute and Foundation, Minneapolis, Minnesota, USA
    Am J Cardiol 107:1541-6. 2011
    ..In conclusion, high-pitch, dual-source computed tomography provides excellent diagnostic accuracy and markedly reduces radiation dose, although image quality is mildly reduced...
  38. ncbi Ionizing radiation and vasculature: hot times for hot arteries
    Robert S Schwartz
    Minnesota Cardiovascular Research Institute, Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA
    Catheter Cardiovasc Interv 62:391-2. 2004
  39. ncbi Patent foramen ovale: current pathology, pathophysiology, and clinical status
    Hidehiko Hara
    Minneapolis Heart Institute and Foundation, Minneapolis, Minnesota, USA
    J Am Coll Cardiol 46:1768-76. 2005
    ..The PFO should be better understood to take advantage of emerging percutaneous treatment options. This paper reviews PFO anatomy, pathology, pathophysiology, and clinical impact and discusses current therapeutic options...
  40. doi Innovations in imaging for chronic total occlusions: a glimpse into the future of angiography's blind-spot
    Brian K Courtney
    Division of Cardiology, Schulich Heart Program, Sunnybrook Health Sciences Centre, Room A 253, 2075 Bayview Avenue, Toronto, Ontario M4N 3M5, Canada
    Eur Heart J 29:583-93. 2008
    ..Strategies that combine imaging techniques with the use of interventional therapies may provide significant opportunities to improve results in CTO interventions and represent an active area of investigation...
  41. ncbi The porcine coronary model of in-stent restenosis: current status in the era of drug-eluting stents
    Harry C Lowe
    Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA
    Catheter Cardiovasc Interv 60:515-23. 2003
    ..Finally, recent pig coronary drug-eluting stent studies are examined, with a discussion of their advantages, limitations, and possible future modifications...
  42. doi Cardiac CTA, three-dimensions, and the chronic total occlusion: a window to the future
    Robert S Schwartz
    Catheter Cardiovasc Interv 71:790-1. 2008
  43. ncbi Clinical and angiographic efficacy of a self-expanding nitinol stent in saphenous vein graft atherosclerotic disease: the Stent Comparative Restenosis (SCORES) Saphenous Vein Graft Registry
    David E Kandzari
    Division of Cardiology, Duke University Medical Center, Durham, NC 27710, USA
    Am Heart J 145:868-74. 2003
    ..The Stent Comparative Restenosis (SCORES) Saphenous Vein Graft (SVG) Registry was a multicenter, prospective registry designed to evaluate the safety and efficacy of a self-expanding, nickel-titanium (nitinol) stent for de novo SVG lesions...
  44. ncbi Beauty's only skin deep: surface technologies emerge in stenting
    Robert S Schwartz
    Catheter Cardiovasc Interv 60:408-9. 2003
  45. ncbi From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II
    Morteza Naghavi
    The Center for Vulnerable Plaque Research, University of Texas Houston, The Texas Heart Institute, and President Bush Center for Cardiovascular Health, Memorial Hermann Hospital, Houston, USA
    Circulation 108:1772-8. 2003
    ..We encourage healthcare policy makers to promote translational research for screening and treatment of vulnerable patients...
  46. ncbi Three-dimensional imaging is here and now: time to prove its relevance
    Robert S Schwartz
    Catheter Cardiovasc Interv 69:483-7. 2007
  47. ncbi Multidetector CT coronary angiography: where we are, and where we are going
    Jamie M Pelzel
    Division of Cardiovascular Disease, University of Minnesota, Minnesota, USA
    Catheter Cardiovasc Interv 69:159-71. 2007
  48. ncbi Diffuse and active inflammation occurs in both vulnerable and stable plaques of the entire coronary tree: a histopathologic study of patients dying of acute myocardial infarction
    Alessandro Mauriello
    Department of Pathology, University of Rome Tor Vergata, Rome, Italy
    J Am Coll Cardiol 45:1585-93. 2005
    ..This study was undertaken to define and compare geographic coronary artery inflammation in patients who were dying of acute myocardial infarction (AMI), chronic stable angina (SA), and noncardiac causes (CTRL)...
  49. ncbi A tissue-engineered stent for cell-based vascular gene transfer
    Carmelo J Panetta
    Division of Cardiovascular Diseases and Molecular Medicine Program, Mayo Clinic, Rochester, MN 55905, USA
    Hum Gene Ther 13:433-41. 2002
    ..This study has implications for treatment of cardiovascular and other diseases where long-term cell-based delivery of transgene is a desirable therapeutic option...
  50. ncbi The effects of granulocyte-colony stimulating factor in bare stent and sirolimus-eluting stent in pigs following myocardial infarction
    Sang Yup Lim
    The Heart Center of Chonnam National University Hospital, Gwangju, South Korea
    Int J Cardiol 118:304-11. 2007
    ..The purpose of this study was to compare the effects of granulocyte-colony stimulating factor (G-CSF) on in-stent restenosis (ISR) in bare and sirolimus-eluting stents (SES) in a porcine myocardial infarction model...
  51. ncbi Macrophages, myofibroblasts and neointimal hyperplasia after coronary artery injury and repair
    Antoni Bayes-Genis
    The Division of Cardiovascular Diseases, Mayo Clinic and Foundation, Rochester, MN, USA
    Atherosclerosis 163:89-98. 2002
    ..This study indicates that hematopoietic cells of monocyte/macrophage lineage abundantly populate the neointima in the process of lesion formation and may be precursors of neointimal myofibroblasts after thermal vascular injury...
  52. ncbi A critical role for elastin signaling in vascular morphogenesis and disease
    Satyajit K Karnik
    Program in Human Molecular Biology and Genetics, University of Utah, Salt Lake City, UT, USA
    Development 130:411-23. 2003
    ..Together, this work demonstrates that signaling pathways crucial for arterial morphogenesis can play an important role in the pathogenesis and treatment of vascular disease...
  53. ncbi From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I
    Morteza Naghavi
    The Center for Vulnerable Plaque Research, University of Texas Houston, The Texas Heart Institute, and President Bush Center for Cardiovascular Health, Memorial Hermann Hospital, Houston, USA
    Circulation 108:1664-72. 2003
    ..We encourage healthcare policy makers to promote translational research for screening and treatment of vulnerable patients...
  54. ncbi Effects of insulin-like growth factor-I on cultured human coronary artery smooth muscle cells
    Antoni Bayes-Genis
    Division of Cardiovascular Diseases and Endocrine Research Unit, Mayo Clinic and Foundation, 200 First Street SW, 5 194 Joseph, Rochester, MN 55905, USA
    Growth Horm IGF Res 13:246-53. 2003
    ..Because CoSMC migration plays a crucial role in atherosclerosis and restenosis, IGF-I blockade has the potential to limit lumen reduction...
  55. ncbi [Unstable carotid plaque: biochemical and cellular marker of vulnerability]
    Giannignazio Luigi Carbone
    Laboratorio di Emodinamica, Istituto Policlinico San Donato, San Donato Milanese, MI
    Ital Heart J Suppl 4:398-406. 2003
    ..However, these biohumoral markers, and their potential combination of techniques, may hold promise for the future characterization of the vulnerable plaque and moreover of the vulnerable patient...
  56. ncbi Clotting and hemorrhage in the placenta--a delicate balance
    Drucilla Roberts
    N Engl J Med 347:57-9. 2002
  57. ncbi Hypertension exacerbates the effect of hypercholesterolemia on the myocardial microvasculature
    Martin Rodriguez-Porcel
    Department of Internal Medicine, Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA
    Cardiovasc Res 58:213-21. 2003
    ..HC and HT are individually associated with abnormal myocardial vascular function, but whether HT exacerbates the HC-induced myocardial vascular dysfunction remains unclear...
  58. ncbi "POBA Plus": will the balloon regain its luster?
    Timothy D Henry
    Circulation 118:1309-11. 2008
  59. ncbi Taking the stent in vein: interventions in the other half of the vascular tree
    Robert S Schwartz
    Catheter Cardiovasc Interv 59:63-5. 2003
  60. ncbi Pregnancy-associated plasma protein-a is markedly expressed by monocyte-macrophage cells in vulnerable and ruptured carotid atherosclerotic plaques: a link between inflammation and cerebrovascular events
    Giuseppe Sangiorgi
    Department of Cardiovascular Disease, Istituto Policlinico San Donato, San Donato Milanese, Milan, Italy
    J Am Coll Cardiol 47:2201-11. 2006
    ..The study aim was to evaluate serologic expression of pregnancy-associated protein-A (PAPP-A) in patients affected by cerebrovascular accidents and to correlate it with histopathologic carotid plaque complexity...
  61. ncbi Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: part I
    Gregg W Stone
    Columbia University Medical Center, Cardiovascular Research Foundation, New York, NY 10022, USA
    Circulation 112:2364-72. 2005
  62. ncbi From vulnerable plaque to vulnerable patient--Part III: Executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report
    Morteza Naghavi
    Association for Eradication of Heart Attack, Houston, Texas 77005, USA
    Am J Cardiol 98:2H-15H. 2006
    ....
  63. ncbi Percutaneous recanalization of chronically occluded coronary arteries: procedural techniques, devices, and results
    Gregg W Stone
    Division of Cardiology, Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York 10022, USA
    Catheter Cardiovasc Interv 66:217-36. 2005
  64. ncbi Changing paradigm for neointimal cell origin: is restenosis a blood-borne disease?
    Youngkeun Ahn
    Department of Cardiovascular Medicine, Heart Center of Chonnam National University Hospital, Chonnam National University Research Institute of Medical Science, Gwangju, South Korea
    Catheter Cardiovasc Interv 64:468-70. 2005
  65. ncbi Wireless acoustic communication with a miniature pressure sensor in the pulmonary artery for disease surveillance and therapy of patients with congestive heart failure
    Yoseph Rozenman
    The Heart Institute, E Wolfson Medical Center, Holon, Israel
    J Am Coll Cardiol 49:784-9. 2007
    ..The purpose of this study was to examine the feasibility of repeated pulmonary artery (PA) pressure determinations using a newly developed acoustic wireless implanted communication system...
  66. ncbi Ionizing radiation and the coronary arteries: is the plot thickening?
    Robert S Schwartz
    Catheter Cardiovasc Interv 63:282-3. 2004
  67. ncbi Extracranial thrombotically active carotid plaque as a risk factor for ischemic stroke
    Luigi Giusto Spagnoli
    Anatomic Pathology, Department of Cardiovascular Diseases, University of Rome Tor Vergata, Rome, Italy
    JAMA 292:1845-52. 2004
    ..Recent studies suggest that factors other than the degree of carotid stenosis are involved in ischemic stroke pathogenesis, especially modifications of plaque composition and related complications...
  68. ncbi Effect of exercise on serum androgens in postmenopausal women: a 12-month randomized clinical trial
    Anne McTiernan
    Cancer Prevention Research Program, Fred Hutchinson Cancer Research Center, and Department of Epidemiology, School of Public Health, University of Washington, Seattle, USA
    Cancer Epidemiol Biomarkers Prev 13:1099-105. 2004
    ..The association between exercise and breast cancer risk may be partly explained by the effects of exercise on these hormones...
  69. ncbi Pennington scientific symposium on mechanisms and retardation of aging
    Craig S Atwood
    Section of Geriatrics and Gerontology, University of Wisconsin Medical School, Madison, WI, USA
    Exp Gerontol 38:1217-26. 2003
  70. doi Vulnerable plaque intervention: State of the art
    John J Young
    Swedish Heart and Vascular Institute, Seattle, Washington 98122, USA
    Catheter Cardiovasc Interv 71:367-74. 2008
    ....
  71. doi Full disclosure and the funding of biomedical research
    Robert S Schwartz
    N Engl J Med 358:1850-1. 2008